Skip to content

VRCA

Verrica Pharmaceuticals Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.45
−4.30%
Ask drillr
6
Insider buys (3m)
0
Insider sells (3m)
$210.9K
Net value (3m)
-18.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026Rieger Jayson · director, officer: CEO and PresidentPurchase5,000$4.91
Aug 18, 2026Rosenberg Noah L. · officer: CMOPurchase2,030$4.92
Aug 18, 2026Rosenberg Noah L. · officer: CMOPurchase4,200$4.91
Aug 18, 2026Rieger Jayson · director, officer: CEO and PresidentPurchase20,000$5.06
Aug 18, 2026Kirby John J. · officer: Interim CFOPurchase5,000$4.93
Aug 18, 2026Zawitz David · officer: Chief Operating OfficerPurchase6,000$4.98
Jun 9, 2026Nguyen Diem · directorA-Award16,000$6.04
Jun 9, 2026Rieger Jayson · director, officer: CEO and PresidentA-Award512,269$8.21
Jun 9, 2026Corcoran Gavin · directorA-Award16,000$6.04
Jun 9, 2026Zawitz David · officer: Chief Operating OfficerA-Award171,340$8.21
Jun 9, 2026Eichenfield Lawrence · directorA-Award16,000$6.04
Jun 9, 2026Rosenberg Noah L. · officer: CMOA-Award233,840$8.21
Jun 9, 2026PRYGOCKI MARK A SR · directorA-Award16,000$6.04
Dec 30, 2025Kirby John J. · officer: Interim CFOA-Award10,000$0.00
Nov 25, 2025Rosenberg Noah L. · officer: CMOPurchase589$6.32
Nov 25, 2025Rosenberg Noah L. · officer: CMOPurchase2,357$4.24
Nov 25, 2025Zawitz David · officer: Chief Operating OfficerPurchase2,500$6.32
Nov 25, 2025Manning Paul B · director, 10 percent owner: Purchase343,845$6.32
Nov 25, 2025Zawitz David · officer: Chief Operating OfficerPurchase10,000$4.24
Nov 25, 2025Manning Paul B · director, 10 percent owner: Purchase687,690$6.32
Nov 25, 2025Manning Paul B · director, 10 percent owner: Purchase2,750,762$4.24
Nov 25, 2025Kirby John J. · officer: Interim CFOPurchase884$6.32
Nov 25, 2025Manning Paul B · director, 10 percent owner: Purchase1,375,380$4.24
Nov 25, 2025Rieger Jayson · director, officer: CEO and PresidentPurchase23,577$6.32
Nov 25, 2025Rieger Jayson · director, officer: CEO and PresidentPurchase94,311$4.24
Nov 25, 2025Kirby John J. · officer: Interim CFOPurchase3,536$4.24
Jun 9, 2025Nguyen Diem · directorA-Award20,000$0.58
Jun 9, 2025PRYGOCKI MARK A SR · directorA-Award20,000$0.58
Jun 9, 2025Eichenfield Lawrence · directorA-Award20,000$0.58
Jun 9, 2025Corcoran Gavin · directorA-Award20,000$0.58
Institutional positioning

13F filings over the trailing two quarters

New 16Increased 16Reduced 20Sold out 6
FilerActionSharesFiled
Caligan Partners LPUnchanged923,910Aug 14, 2026
CALIGAN PARTNERS LPUnchanged923,910May 15, 2026
CANNELL CAPITAL LLCIncreased783,923Aug 18, 2026
Affinity Asset Advisors, LLCUnchanged707,338Aug 13, 2026
AFFINITY ASSET ADVISORS, LLCUnchanged707,338May 14, 2026
CANNELL CAPITAL LLCNew Position685,123May 15, 2026
ARMISTICE CAPITAL, LLCReduced518,181May 15, 2026
VELAN CAPITAL INVESTMENT MANAGEMENT LPUnchanged471,559May 15, 2026
Velan Capital Investment Management LPUnchanged471,559Aug 14, 2026
ARMISTICE CAPITAL, LLCReduced426,304Aug 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged280,734Aug 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged280,734May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased279,310Aug 13, 2026
Mariner, LLCIncreased207,230Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position188,758May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026